Cover Image
Market Research Report
Product code 
1093035

Europe Sepsis Diagnostics Market Size, Share & Industry Trends Analysis Report By Method, By Test Type, By Pathogen, By Product, By End-User, By Technology, By Country and Growth Forecast, 2022 - 2028

Published: | KBV Research | 140 Pages | Delivery time: 1-2 business days

Price

Back to Top
Europe Sepsis Diagnostics Market Size, Share & Industry Trends Analysis Report By Method, By Test Type, By Pathogen, By Product, By End-User, By Technology, By Country and Growth Forecast, 2022 - 2028
Published: April 29, 2022
KBV Research
Content info: 140 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

The Europe Sepsis Diagnostics Market would witness market growth of 7.6% CAGR during the forecast period (2022-2028).

It harms the tissues and organs of its own body. Physicians classify sepsis as a three-staged illness that begins with sepsis and progresses to severe sepsis and lastly septic shock. Severe sepsis is linked to organ failure and a rapid change in the mental status of the patient. Septic shock is a medical emergency classified as severe sepsis with symptoms of aberrant cellular metabolism, rapid drops in blood pressure, and organ malfunction. Sepsis is a dangerous consequence that results from a weakened immune system, making people vulnerable to viral, bacterial, parasitic, fungal, and other illnesses. In hospitals, sepsis is amongst the leading causes of death. When the patient's immune system responds to an infection, chemicals are released by the immune system to treat the infection, resulting in sepsis.

Sepsis creates levels of inflammation as it enters the bloodstream. It produces blood vessel leakage, blood clots, and poor blood flow, denying oxygen and nutrition to the body's vital organs. People with weak immune systems, youngsters, the elderly, and those suffering from chronic illnesses including cancer, AIDS, diabetes, and others are at a higher risk of acquiring sepsis.

According to several surveys, the death rate related to sepsis slowly declining in Germany. This is mostly due to improved healthcare services across the country along with the rising utilization of the sepsis diagnostic approaches. In addition, there is a rising scale of awareness in regional population about the disorder, and health professionals are getting more skilled. As a result of these advancements, diagnosing the condition has become much easier and more efficient.

In addition, developed countries across the region comprise a robust and well-established research and development infrastructure, which has attracted the interest of several foreign firms.

In France, on the other hand, the market is primarily driven by an increase in sepsis cases, along with the increase in the number of diagnostics businesses establishing operations in the country. As per the Pasteur Institute, a non-profit organization committed to conduct research on illnesses and vaccines, sepsis cases are projected to increase in the next 50 years as the aging population grows. This places a significant strain on the healthcare system, driving up demand for sepsis detection and treatment and bolstering the growth of the French sepsis diagnostics market.

The Germany market dominated the Europe Sepsis Diagnostics Market by Country in 2021, and would continue to be a dominant market till 2018; thereby, achieving a market value of $57.2 million by 2028. The UK market is estimated to grow at a CAGR of 6.7% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 8.4% during (2022 - 2028).

Based on Method, the market is segmented into Conventional and Automated. Based on Test Type, the market is segmented into Laboratory Tests and Point-of-Care Tests. Based on Pathogen, the market is segmented into Bacterial Sepsis, Fungal Sepsis, Viral Sepsis, and Others. Based on Product, the market is segmented into Blood Culture Media, Assays & Reagents, Instruments, and Software. Based on End-User, the market is segmented into Hospitals & specialty clinics, Pathology & Reference Laboratories, and Research Laboratories & Academic Institutes. Based on Technology, the market is segmented into Blood Culture, Immunoassays, Molecular Diagnostics, Flow Cytometry, Microfluidics, and Biomarkers. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BioMerieux S.A., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Abbott Laboratories, Thermo Fisher Scientific, Inc., DiaSorin S.p.A., Bruker Corporation, Siemens Healthineers AG, Danaher Corporation, and Quidel Corporation.

Scope of the Study

Market Segments covered in the Report:

By Method

  • Conventional
  • Automated

By Test Type

  • Laboratory Tests
  • Point-of-Care Tests

By Pathogen

  • Bacterial Sepsis
  • Fungal Sepsis
  • Viral Sepsis
  • Others

By Product

  • Blood Culture Media
  • Assays & Reagents
  • Instruments
  • Software

By End-User

  • Hospitals & specialty clinics
  • Pathology & Reference Laboratories
  • Research Laboratories & Academic Institutes

By Technology

  • Blood Culture
  • Immunoassays
  • Molecular Diagnostics
  • Flow Cytometry
  • Microfluidics
  • Biomarkers

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled

  • BioMerieux S.A.
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • DiaSorin S.p.A.
  • Bruker Corporation
  • Siemens Healthineers AG
  • Danaher Corporation
  • Quidel Corporation

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Europe Sepsis Diagnostics Market, by Method
    • 1.4.2 Europe Sepsis Diagnostics Market, by Test Type
    • 1.4.3 Europe Sepsis Diagnostics Market, by Pathogen
    • 1.4.4 Europe Sepsis Diagnostics Market, by Product
    • 1.4.5 Europe Sepsis Diagnostics Market, by End-User
    • 1.4.6 Europe Sepsis Diagnostics Market, by Technology
    • 1.4.7 Europe Sepsis Diagnostics Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
    • 3.2.4 Approvals and Trials
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
    • 3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul - 2021, Dec) Leading Players

Chapter 4. Europe Sepsis Diagnostics Market by Method

  • 4.1 Europe Conventional Market by Country
  • 4.2 Europe Automated Market by Country

Chapter 5. Europe Sepsis Diagnostics Market by Test Type

  • 5.1 Europe Laboratory Tests Market by Country
  • 5.2 Europe Point-of-Care Tests Market by Country

Chapter 6. Europe Sepsis Diagnostics Market by Pathogen

  • 6.1 Europe Bacterial Sepsis Market by Country
  • 6.2 Europe Fungal Sepsis Market by Country
  • 6.3 Europe Viral Sepsis Market by Country
  • 6.4 Europe Others Market by Country

Chapter 7. Europe Sepsis Diagnostics Market by Product

  • 7.1 Europe Blood Culture Media Market by Country
  • 7.2 Europe Assays & Reagents Market by Country
  • 7.3 Europe Instruments Market by Country
  • 7.4 Europe Software Market by Country

Chapter 8. Europe Sepsis Diagnostics Market by End-User

  • 8.1 Europe Hospitals & specialty clinics Market by Country
  • 8.2 Europe Pathology & Reference Laboratories Market by Country
  • 8.3 Europe Research Laboratories & Academic Institutes Market by Country

Chapter 9. Europe Sepsis Diagnostics Market by Technology

  • 9.1 Europe Blood Culture Market by Country
  • 9.2 Europe Immunoassays Market by Country
  • 9.3 Europe Molecular Diagnostics Market by Country
  • 9.4 Europe Flow Cytometry Market by Country
  • 9.5 Europe Microfluidics Market by Country
  • 9.6 Europe Biomarkers Market by Country

Chapter 10. Europe Sepsis Diagnostics Market by Country

  • 10.1 Germany Sepsis Diagnostics Market
    • 10.1.1 Germany Sepsis Diagnostics Market by Method
    • 10.1.2 Germany Sepsis Diagnostics Market by Test Type
    • 10.1.3 Germany Sepsis Diagnostics Market by Pathogen
    • 10.1.4 Germany Sepsis Diagnostics Market by Product
    • 10.1.5 Germany Sepsis Diagnostics Market by End-User
    • 10.1.6 Germany Sepsis Diagnostics Market by Technology
  • 10.2 UK Sepsis Diagnostics Market
    • 10.2.1 UK Sepsis Diagnostics Market by Method
    • 10.2.2 UK Sepsis Diagnostics Market by Test Type
    • 10.2.3 UK Sepsis Diagnostics Market by Pathogen
    • 10.2.4 UK Sepsis Diagnostics Market by Product
    • 10.2.5 UK Sepsis Diagnostics Market by End-User
    • 10.2.6 UK Sepsis Diagnostics Market by Technology
  • 10.3 France Sepsis Diagnostics Market
    • 10.3.1 France Sepsis Diagnostics Market by Method
    • 10.3.2 France Sepsis Diagnostics Market by Test Type
    • 10.3.3 France Sepsis Diagnostics Market by Pathogen
    • 10.3.4 France Sepsis Diagnostics Market by Product
    • 10.3.5 France Sepsis Diagnostics Market by End-User
    • 10.3.6 France Sepsis Diagnostics Market by Technology
  • 10.4 Russia Sepsis Diagnostics Market
    • 10.4.1 Russia Sepsis Diagnostics Market by Method
    • 10.4.2 Russia Sepsis Diagnostics Market by Test Type
    • 10.4.3 Russia Sepsis Diagnostics Market by Pathogen
    • 10.4.4 Russia Sepsis Diagnostics Market by Product
    • 10.4.5 Russia Sepsis Diagnostics Market by End-User
    • 10.4.6 Russia Sepsis Diagnostics Market by Technology
  • 10.5 Spain Sepsis Diagnostics Market
    • 10.5.1 Spain Sepsis Diagnostics Market by Method
    • 10.5.2 Spain Sepsis Diagnostics Market by Test Type
    • 10.5.3 Spain Sepsis Diagnostics Market by Pathogen
    • 10.5.4 Spain Sepsis Diagnostics Market by Product
    • 10.5.5 Spain Sepsis Diagnostics Market by End-User
    • 10.5.6 Spain Sepsis Diagnostics Market by Technology
  • 10.6 Italy Sepsis Diagnostics Market
    • 10.6.1 Italy Sepsis Diagnostics Market by Method
    • 10.6.2 Italy Sepsis Diagnostics Market by Test Type
    • 10.6.3 Italy Sepsis Diagnostics Market by Pathogen
    • 10.6.4 Italy Sepsis Diagnostics Market by Product
    • 10.6.5 Italy Sepsis Diagnostics Market by End-User
    • 10.6.6 Italy Sepsis Diagnostics Market by Technology
  • 10.7 Rest of Europe Sepsis Diagnostics Market
    • 10.7.1 Rest of Europe Sepsis Diagnostics Market by Method
    • 10.7.2 Rest of Europe Sepsis Diagnostics Market by Test Type
    • 10.7.3 Rest of Europe Sepsis Diagnostics Market by Pathogen
    • 10.7.4 Rest of Europe Sepsis Diagnostics Market by Product
    • 10.7.5 Rest of Europe Sepsis Diagnostics Market by End-User
    • 10.7.6 Rest of Europe Sepsis Diagnostics Market by Technology

Chapter 11. Company Profiles

  • 11.1 BioMerieux S.A.
    • 11.1.1 Company Overview
    • 11.1.2 Financial Analysis
    • 11.1.3 Segmental and Regional Analysis
    • 11.1.4 Research & Development Expenses
    • 11.1.5 Recent strategies and developments:
      • 11.1.5.1 Acquisition and Mergers:
  • 11.2 F. Hoffmann-La Roche Ltd.
    • 11.2.1 Company Overview
    • 11.2.2 Financial Analysis
    • 11.2.3 Segmental and Regional Analysis
    • 11.2.4 Research & Development Expense
    • 11.2.5 Recent strategies and developments:
      • 11.2.5.1 Partnerships, Collaborations, and Agreements:
      • 11.2.5.2 Approvals and Trials:
  • 11.3 Becton, Dickinson and Company
    • 11.3.1 Company Overview
    • 11.3.2 Financial Analysis
    • 11.3.3 Segmental and Regional Analysis
    • 11.3.4 Research & Development Expense
    • 11.3.5 Recent strategies and developments:
      • 11.3.5.1 Product Launches and Product Expansions:
  • 11.4 Abbott Laboratories
    • 11.4.1 Company Overview
    • 11.4.2 Financial Analysis
    • 11.4.3 Segmental and Regional Analysis
    • 11.4.4 Research & Development Expense
    • 11.4.5 Recent strategies and developments:
      • 11.4.5.1 Acquisition and Mergers:
  • 11.5 Thermo Fisher Scientific, Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Financial Analysis
    • 11.5.3 Segmental and Regional Analysis
    • 11.5.4 Research & Development Expense
    • 11.5.5 Recent strategies and developments:
      • 11.5.5.1 Partnerships, Collaborations, and Agreements:
      • 11.5.5.2 Approvals and Trials:
      • 11.5.5.3 Acquisition and Mergers:
    • 11.5.6 SWOT Analysis
  • 11.6 DiaSorin S.p.A. (Luminex Corporation)
    • 11.6.1 Company Overview
    • 11.6.2 Financial Analysis
    • 11.6.3 Regional Analysis
    • 11.6.4 Research & Development Expenses
    • 11.6.5 Recent strategies and developments:
      • 11.6.5.1 Acquisitions and Mergers:
  • 11.7 Bruker Corporation
    • 11.7.1 Company Overview
    • 11.7.2 Financial Analysis
    • 11.7.3 Segmental and Regional Analysis
    • 11.7.4 Research & Development Expense
    • 11.7.5 Recent strategies and developments:
      • 11.7.5.1 Product Launches and Product Expansions:
      • 11.7.5.2 Acquisition and Mergers:
  • 11.8 Siemens Healthineers AG (Siemens AG)
    • 11.8.1 Company Overview
    • 11.8.2 Financial Analysis
    • 11.8.3 Segmental and Regional Analysis
    • 11.8.4 Research & Development Expenses
    • 11.8.5 Recent strategies and developments:
      • 11.8.5.1 Partnerships, Collaborations, and Agreements:
      • 11.8.5.2 Acquisition and Mergers:
  • 11.9 Danaher Corporation
    • 11.9.1 Company Overview
    • 11.9.2 Financial Analysis
    • 11.9.3 Segmental and Regional Analysis
    • 11.9.4 Research & Development Expense
  • 11.10. Quidel Corporation
    • 11.10.1 Company Overview
    • 11.10.2 Financial Analysis
    • 11.10.3 Regional Analysis
    • 11.10.4 Research & Development Expense
    • 11.10.5 Recent strategies and developments:
      • 11.10.5.1 Acquisition and Mergers:

LIST OF TABLES

  • TABLE 1 Europe Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 2 Europe Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements - Sepsis Diagnostics Market
  • TABLE 4 Product Launches And Product Expansions - Sepsis Diagnostics Market
  • TABLE 5 Acquisition and Mergers - Sepsis Diagnostics Market
  • TABLE 6 Approvals and Trials - Sepsis Diagnostics Market
  • TABLE 7 Europe Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 8 Europe Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 9 Europe Conventional Market by Country, 2018 - 2021, USD Million
  • TABLE 10 Europe Conventional Market by Country, 2022 - 2028, USD Million
  • TABLE 11 Europe Automated Market by Country, 2018 - 2021, USD Million
  • TABLE 12 Europe Automated Market by Country, 2022 - 2028, USD Million
  • TABLE 13 Europe Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 14 Europe Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 15 Europe Laboratory Tests Market by Country, 2018 - 2021, USD Million
  • TABLE 16 Europe Laboratory Tests Market by Country, 2022 - 2028, USD Million
  • TABLE 17 Europe Point-of-Care Tests Market by Country, 2018 - 2021, USD Million
  • TABLE 18 Europe Point-of-Care Tests Market by Country, 2022 - 2028, USD Million
  • TABLE 19 Europe Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 20 Europe Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 21 Europe Bacterial Sepsis Market by Country, 2018 - 2021, USD Million
  • TABLE 22 Europe Bacterial Sepsis Market by Country, 2022 - 2028, USD Million
  • TABLE 23 Europe Fungal Sepsis Market by Country, 2018 - 2021, USD Million
  • TABLE 24 Europe Fungal Sepsis Market by Country, 2022 - 2028, USD Million
  • TABLE 25 Europe Viral Sepsis Market by Country, 2018 - 2021, USD Million
  • TABLE 26 Europe Viral Sepsis Market by Country, 2022 - 2028, USD Million
  • TABLE 27 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 28 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 29 Europe Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 30 Europe Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 31 Europe Blood Culture Media Market by Country, 2018 - 2021, USD Million
  • TABLE 32 Europe Blood Culture Media Market by Country, 2022 - 2028, USD Million
  • TABLE 33 Europe Assays & Reagents Market by Country, 2018 - 2021, USD Million
  • TABLE 34 Europe Assays & Reagents Market by Country, 2022 - 2028, USD Million
  • TABLE 35 Europe Instruments Market by Country, 2018 - 2021, USD Million
  • TABLE 36 Europe Instruments Market by Country, 2022 - 2028, USD Million
  • TABLE 37 Europe Software Market by Country, 2018 - 2021, USD Million
  • TABLE 38 Europe Software Market by Country, 2022 - 2028, USD Million
  • TABLE 39 Europe Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 40 Europe Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 41 Europe Hospitals & specialty clinics Market by Country, 2018 - 2021, USD Million
  • TABLE 42 Europe Hospitals & specialty clinics Market by Country, 2022 - 2028, USD Million
  • TABLE 43 Europe Pathology & Reference Laboratories Market by Country, 2018 - 2021, USD Million
  • TABLE 44 Europe Pathology & Reference Laboratories Market by Country, 2022 - 2028, USD Million
  • TABLE 45 Europe Research Laboratories & Academic Institutes Market by Country, 2018 - 2021, USD Million
  • TABLE 46 Europe Research Laboratories & Academic Institutes Market by Country, 2022 - 2028, USD Million
  • TABLE 47 Europe Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 48 Europe Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 49 Europe Blood Culture Market by Country, 2018 - 2021, USD Million
  • TABLE 50 Europe Blood Culture Market by Country, 2022 - 2028, USD Million
  • TABLE 51 Europe Immunoassays Market by Country, 2018 - 2021, USD Million
  • TABLE 52 Europe Immunoassays Market by Country, 2022 - 2028, USD Million
  • TABLE 53 Europe Molecular Diagnostics Market by Country, 2018 - 2021, USD Million
  • TABLE 54 Europe Molecular Diagnostics Market by Country, 2022 - 2028, USD Million
  • TABLE 55 Europe Flow Cytometry Market by Country, 2018 - 2021, USD Million
  • TABLE 56 Europe Flow Cytometry Market by Country, 2022 - 2028, USD Million
  • TABLE 57 Europe Microfluidics Market by Country, 2018 - 2021, USD Million
  • TABLE 58 Europe Microfluidics Market by Country, 2022 - 2028, USD Million
  • TABLE 59 Europe Biomarkers Market by Country, 2018 - 2021, USD Million
  • TABLE 60 Europe Biomarkers Market by Country, 2022 - 2028, USD Million
  • TABLE 61 Europe Sepsis Diagnostics Market by Country, 2018 - 2021, USD Million
  • TABLE 62 Europe Sepsis Diagnostics Market by Country, 2022 - 2028, USD Million
  • TABLE 63 Germany Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 64 Germany Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 65 Germany Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 66 Germany Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 67 Germany Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 68 Germany Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 69 Germany Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 70 Germany Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 71 Germany Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 72 Germany Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 73 Germany Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 74 Germany Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 75 Germany Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 76 Germany Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 77 UK Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 78 UK Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 79 UK Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 80 UK Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 81 UK Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 82 UK Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 83 UK Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 84 UK Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 85 UK Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 86 UK Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 87 UK Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 88 UK Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 89 UK Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 90 UK Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 91 France Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 92 France Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 93 France Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 94 France Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 95 France Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 96 France Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 97 France Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 98 France Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 99 France Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 100 France Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 101 France Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 102 France Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 103 France Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 104 France Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 105 Russia Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 106 Russia Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 107 Russia Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 108 Russia Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 109 Russia Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 110 Russia Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 111 Russia Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 112 Russia Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 113 Russia Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 114 Russia Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 115 Russia Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 116 Russia Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 117 Russia Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 118 Russia Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 119 Spain Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 120 Spain Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 121 Spain Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 122 Spain Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 123 Spain Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 124 Spain Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 125 Spain Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 126 Spain Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 127 Spain Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 128 Spain Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 129 Spain Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 130 Spain Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 131 Spain Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 132 Spain Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 133 Italy Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 134 Italy Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 135 Italy Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 136 Italy Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 137 Italy Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 138 Italy Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 139 Italy Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 140 Italy Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 141 Italy Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 142 Italy Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 143 Italy Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 144 Italy Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 145 Italy Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 146 Italy Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 147 Rest of Europe Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 148 Rest of Europe Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 149 Rest of Europe Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 150 Rest of Europe Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 151 Rest of Europe Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 152 Rest of Europe Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 153 Rest of Europe Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 154 Rest of Europe Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 155 Rest of Europe Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 156 Rest of Europe Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 157 Rest of Europe Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 158 Rest of Europe Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 159 Rest of Europe Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 160 Rest of Europe Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 161 Key information - BioMerieux S.A.
  • TABLE 162 KEY INFORMATION - F. HOFFMANN-LA ROCHE LTD.
  • TABLE 163 Key information - Becton, Dickinson and Company
  • TABLE 164 Key Information - Abbott Laboratories
  • TABLE 165 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 166 Key Information - DiaSorin S.p.A.
  • TABLE 167 Key Information - Bruker Corporation
  • TABLE 168 Key Information - Siemens Healthineers AG
  • TABLE 169 Key Information - Danaher Corporation
  • TABLE 170 key information - Quidel Corporation

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
  • FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul - 2021, Dec) Leading Players
  • FIG 5 Recent strategies and developments: Thermo Fisher Scientific, Inc.
  • FIG 6 Swot analysis: thermo fisher scientific, inc.
  • FIG 7 Recent strategies and developments: Bruker Corporation